Inês Moreira

Cátia Amaro

06 May 2025

How AI Is Transforming PET/CT Analysis

Analysing these scans can also be time-consuming and complex, as doctors need to pore over countless images, looking for often tiny details.

So, any new imaging analysis technique that is faster and more precise is always welcome: a new paper (recently published in the Journal of Nuclear Medicine) reveals that the Champalimaud Foundation’s Nuclear Medicine-Radiopharmacology Unit has managed just that by using Deep Learning (DL) Artificial Intelligence (AI).

05 May. 2025

Rodent Research Technician

Research
Application Starts: 05 May. 2025

Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Rodent Research Technician to join our team. 

An Epigenetic Journey into the Origin, Evolutionary Dynamics and Progression of Chronic Lymphocytic Leukemia

Host

Cristina João, MD, PhD, Myeloma Lymphoma Research Group


Venue

Seminar room

Medica AI - The Conference

The future of medicine is being redefined by artificial intelligence. From digital twins and precision medicine to AI-driven medical imaging and large language models, cutting-edge technologies are transforming the way we diagnose, treat, and prevent disease.

Targeting TCR and Co-Receptor Signalling in T Cells Using Engineered Ligands

Host

Inês Ramos, PhD, Tissue Immunity


Venue

Seminar room

29 April 2025

Champalimaud Foundation’s Henrique Veiga-Fernandes named Portugal’s sole ERC Ambassador

Chosen from over 200 applicants across Europe and associated countries, Veiga-Fernandes was one of just 32 scientists ultimately appointed as ERC Ambassadors. The final selection aimed to balance gender, seniority, and the representation of both current ERC grant holders and different countries. The 32 ambassadors represent 21 EU Member States and four Associated Countries – Israel, Norway, Turkey, and the United Kingdom – plus Switzerland.

21 April 2025

Things You Should Know about the Science behind Exercise and Cancer

The conference Moving Beyond, which took place at the Champalimaud Foundation on April 3 and 4, 2025, was organised to gather world scientific leaders in the field of “exercise oncology”.

During the two-day conference, we interviewed a series of invited speakers on the benefits of physical activity for cancer prevention and treatment and asked speakers to share some of the key scientific advances in exercise oncology.

Watch the video and hear what they had to say — we hope you enjoy it!

16 April 2025

Research at Champalimaud Foundation Awarded 'Excellent' Rating in FCT's R&D Units Evaluation

This recognition affirms the dedication and collaborative effort of countless individuals over the years in building the diverse and sophisticated infrastructure necessary to support a world-class, cutting-edge biomedical research centre.

Subscribe to Cancer
Loading
Please wait...